Ingreso de Usuario 0 Carrito de Compras
Inicio Libros eLibros Revistas Referencias y Libros de Ponencias Autores, Editores, Críticos Índice de Productos de la A a la Z

ISSN Imprimir: 0743-4863

ISSN En Línea: 2162-660X

Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72
SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6
Editor-in-Chief: Mandip Sachdeva
Associate Editor: James Birchall
PUBLISHING DURING
COVID-19

Critical Reviews™ in Therapeutic Drug Carrier Systems

Objetivos y Alcance

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
Inicio Libros eLibros Revistas Referencias y Libros de Ponencias Autores, Editores, Críticos Índice de Productos de la A a la Z Precios y Políticas de Suscripciones Sobre Begell House Contáctenos